Generic Restasis plans revealed days after patent invalidation


A San Diego-based company has announced plans to sell a generic version of Allergan’s dry eye disease treatment Restasis (cyclosporine ophthalmic emulsion), just days after four patents covering the drug were invalidated.

Generics, Restasis, patent invalidation; Allergan; Saint Regis Mohawk Tribe; Judge William Bryson; dry eye disease; Imprimis Pharmaceuticals